Regenxbio Inc at Bank of America Global Healthcare Conference Transcript
Okay. So let's get going. Hey, everyone, good afternoon. Welcome to the last session of day 2 of the 2023 BofA Healthcare Conference. Thanks for joining the session with REGENXBIO. My name is Alec Stranahan, I'm a Vice President and Senior Biotech Analyst covering REGENX here at BofA.
And I'm pleased to be joined by Ken Mills, President and Chief Executive Officer of REGENXBIO, as well as Steve Pakola, REGENXBIO's Chief Medical Officer. Thanks for being here, guys.
Thanks for having us.
Great. So Ken, do you want to maybe kick off with some prepared remarks and then we can jump into the Q&A.
We're even unprepared. Either way, I think there'll be something that I hope lands well on folks. It's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
